Inhalation

INH0225

Issue link: https://www.e-digitaleditions.com/i/1532011

Contents of this Issue

Navigation

Page 33 of 38

32 February 2025 Inhalation Formulation development for low GWP pMDIs Bespak offers a fully integrated service for developing and manufacturing inhaled and nasal drug products, devices and components for the global pharmaceu- tical market. With a long history in the develop- ment and commercial supply of pressurized metered dose inhalers (pMDIs), Bespak has deep expertise in pMDI drug product formulation as well as compo- nentry. Bespak is channeling this expertise to drive sustainability in the industry, offering capabilities and established capacity—with ongoing expansions—for the development and manufacture of pMDIs with low global warming potential (GWP) propellants. Bespak UK: +44 1477 537112 enquiries@bespak.com www.bespak.com Inhaled drug delivery services Vectura provides innovative inhaled drug delivery services, with 25 years of experience helping custom- ers succeed in bringing inhaled medicines to market. Combining formulation development expertise and differentiated proprietary technology from pre-clinical to commercial phases, Vectura has expertise in deliver- ing a broad range of complex inhaled therapies across a variety of platforms, including dry powder inhalers (DPIs), pressurized metered dose inhalers (pMDIs) and nebulizer products for small molecules, biologics, complex combinations and generic products. Vectura UK: +44 1249 667700 info@vectura.com www.vectura.com DPI development and manufacturing services Experic's experienced team provides customized spray drying, precision filling, analytical support and pack- aging solutions at clinical and commercial scale for reservoir and single-dose dry powder inhalation (DPI) products. From formulation development and GMP manufacturing in low humidity environments to clin- ical trial supplies and global logistics, Experic offers services that can solve development and manufactur- ing challenges, accelerate time to market, and mitigate risk for inhalation products with a range of properties. Experic, LLC US: +1 609 537-4040 www.expericservices.com DPI and nasal delivery formulation, device and manufacturing Hovione provides specialist expertise and leadership in particle engineering and formulation develop- ment to ensure that your inhalation and nasal ther- apies are engineered for success from start to finish. Fully integrated in one site, Hovione offers simple, patented and globally competitive dry powder inhal- ers—disposable, capsule, blister, large dose and high performance DPIs—which are available for fully integrated, turnkey development with formulation and for licensing. Expanding our inhalation offering, Hovione provides advanced nasal powder delivery devices, designed for local, systemic and nose-to- brain applications. Hovione—Delivering solutions, every breath of the way. Hovione Portugal: +351 21 982 9000 hovione.com/contact-us www.hovione.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0225